SCIENCE AT THE SPEED OF BUSINESS

Our fundamental premise is that innovative methods, analytical rigor, and scientific acumen can be provided in a commercial entity that operates “at the speed of business.” Monument Analytics delivers.

Unparalleled Knowledge Base

One of the most remarkable features of Monument Analytics is its access to consultants with an unparalleled knowledge base. Through its independent consulting services, Monument Analytics leverages this acumen to assist clients developing products and services for the benefit of society.

Top Notch Evidence

By capitalizing on this unparalleled depth and breadth of human capital, Monument Analytics is able to generate the highest quality evidence regarding the safety, effectiveness, and real-world value of the full range of medical processes and technologies; and to use this knowledge to help our clients navigate evermore complex and challenging regulatory and payment environments.

Internationally Renowned Experts

Our Principals and Consultants are internationally renowned for their expertise in areas ranging from epidemiology and biostatistics to clinical fields such as cardiovascular medicine, oncology, and immunology.

G. Caleb Alexander
G. Caleb AlexanderMD, MS
CO-FOUNDER & PRINCIPAL
Jonothan C. Tierce
Jonothan C. TierceCPhil
CO-FOUNDER & PRINCIPAL
William V. Padula
William V. PadulaPhD
PRINCIPAL
Natalie Reid
Natalie ReidPhD, MPH, MBA
DIRECTOR

MEET THE WHOLE TEAM

MEET THE MA CONSULTANTS

Services

Our services are broadly organized into four core capabilities

  • Comparative effectiveness analyses
  • Pharmacovigilance and safety assessments
  • Investigations of drug utilization
  • Risk-benefit appraisals
  • Bayesian, meta-analytic and systematic reviews
  • Patient and clinician preferences
  • Global marketplace and pharmaceutical policy
  • Design and conduct of sophisticated comparative effectiveness, pharmacovigilance, and drug utilization studies
  • Advanced techniques for causal inference, management of missing data, and other statistical analysis
  • Cost-benefit analysis and cost-effectiveness analysis
  • Natural history of disease and resource utilization
  • Systematic economic and quality-of-life reviews
  • Core value dossiers

MA in the News

May 18, 2020 Bill Padula Dr. William Padula, Monument Analytics’ Principal, co-authored a piece in Modern Healthcare on global budgets during Covid-19 in, “Global budgets offer financial cushion amid the coronavirus pandemic.

May 18, 2020 Monument Analytics The Monument Analytics team in collaboration with our partners, Popper and Company, abstract and poster was accepted and presented at US ISPOR 2020: “Using Information From The Microbiome To Improve The Efficacy Of Selecting Therapeutic Options For Melanoma: A Cost-Effectiveness Analysis.”

May 18, 2020 Natalie Reid & Bill Padula Monument Analytics’ Director, Dr. Natalie Reid, and Principal, Dr. Bill Padula’s abstract was accepted and presented at US ISPOR 2020, “Cooking At Home Can Save Money, Regardless Of Food Price: A Multilevel Analysis Of Meals Preapred Away From The Home On Diet Measures and Food Expenditures.

May 18, 2020 Natalie Reid & Bill Padula Monument Analytics’ Director, Dr. Natalie Reid, and Principal, Dr. Bill Padula’s abstract was accepted and presented at US ISPOR 2020, “Smart Spending: Reallocating Americans’ Food Budgets To Save Costs And Improve Diet Quality.

May 18, 2020 Bill Padula Dr. Bill Padula, Monument Analytics’ Principal, participates in ISPOR workshop, “Tailoring Opportunity Costs To State Budgets And Cost-Effectiveness Thresholds- How To Broaden The Impact Of Value Assessment In The U.S. With State And Commercial Payers.” Available online until June 30, 2020.

May 18, 2020 Bill Padula & Jon Tierce Monument Analytics’ Principals, Bill Padula and Jonothan Tierce, host an ISPOR workshop, “Understanding Intricacies of Value Assessment – Learning How To Conduct Economic Evaluation Of Health Services And What Makes This Approach Different From Health Technology Assessment.” Available online until June 30, 2020.

May 14, 2020 Monument Analytics The Monument Analytics team in collaboration with our partners, Popper and Company, abstract and poster was accepted and presented at US ISPOR 2020: “Using Information From The Microbiome To Improve The Efficacy Of Selecting Therapeutic Options For Melanoma: A Cost-Effectiveness Analysis.”

May 12, 2020 Caleb Alexander Dr. Caleb Alexander, Prinicipal and Co-Founder, co-authors paper to protect the U.S. drug supply chain.

May 7, 2020 Monument Analytics Monument Analytics’ Principal and Co-Founder, Dr. Caleb Alexander, was featured in a piece analyzing drug interactions for Covid-19 treatments in, “Drug-Drug Interactions Could Imperil Covid-19 Treatment.”

April 10, 2020 Caleb Alexander Searching for an effective Covid-19 treatment: promise and peril, co-authored by Monument Analytic’s Co-Founder and Prinicipal, Dr. Caleb Alexander.

April 8, 2020 Bill Padula A health care draft could help unemployment and front line burden in response to COVID-19, co-authored by Monument Analytic’s Principal, Dr. William Padula.

January/February 2019 Bill Padula Dr. Padula, Principal at Monument Analytics, was featured in the ISPOR Member Spotlight in the feature, “Is Pharmacotherapy Enough to Manage The Opioid Crisis?”

November/December 2019 Jon Tierce, Francine Chingcuanco Monument Analytics’ Jon Tierce and Fran Chingcuanco authored a piece titled, “Improving Surgical Site Infection Prevention” featued an interview with Dr. Padula.